<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:atom="http://www.w3.org/2005/Atom"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
>
<channel>
	<title>ThaiPR.NET</title>
	<atom:link href="https://www.thaipr.net/tag/bionet-asia/feed" rel="self" type="application/rss+xml" />
	<link>https://www.thaipr.net/tag/bionet-asia</link>
	<description>Press Release Distribution Center of Thailand</description>
	<lastBuildDate>Thu, 16 Apr 2026 17:30:29 +0700</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.1.1</generator>
	<item>
		<title><![CDATA[BioNet Receives Positive CHMP Opinion from EMA for VacPertagen, a Recombinant Vaccine Against Pertussis]]></title>
		<link>https://www.thaipr.net/en/general_en/3668242</link>
		<dc:creator><![CDATA[thaipr.net]]></dc:creator>
		<pubDate>Fri, 21 Nov 2025 14:54:39 +0700</pubDate>
				<category>business_en</category>
		<guid isPermaLink="false">https://www.thaipr.net/?p=3668242</guid>

					<description><![CDATA[<p>BioNet, a biotechnology company dedicated to innovative vaccines, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion under the centralised procedure recommending marketing authorisation for VacPertagen for booster immunisation in individuals 12 years onwards and passive immunisation during pregnancy. Prof. Emeritus [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://www.thaipr.net/en/general_en/3668242">BioNet Receives Positive CHMP Opinion from EMA for VacPertagen, a Recombinant Vaccine Against Pertussis</a> appeared first on <a rel="nofollow" href="https://www.thaipr.net">ThaiPR.NET</a>.</p>
]]></description>
									</item>
	</channel>
</rss>
